Market closedNon-fractional
Codexis/CDXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Codexis
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
Ticker
CDXS
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Redwood City, United States
Employees
174
Website
www.codexis.com
Codexis Metrics
BasicAdvanced
$203M
Market cap
-
P/E ratio
-$0.94
EPS
2.10
Beta
-
Dividend rate
Price and volume
Market cap
$203M
Beta
2.1
Financial strength
Current ratio
3.712
Quick ratio
3.429
Long term debt to equity
49.622
Total debt to equity
54.516
Management effectiveness
Return on assets (TTM)
-14.65%
Return on equity (TTM)
-63.45%
Valuation
Price to revenue (TTM)
2.681
Price to book
2.55
Price to tangible book (TTM)
2.63
Price to free cash flow (TTM)
-3.671
Growth
Revenue change (TTM)
-36.13%
Earnings per share change (TTM)
29.09%
3-year revenue growth
0.83%
3-year earnings per share growth
31.04%
What the Analysts think about Codexis
Analyst Ratings
Majority rating from 8 analysts.
Codexis Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$17M
-35.85%
Net income
-$12M
61.97%
Profit margin
-67.64%
152.48%
Codexis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.17
-$0.50
-$0.10
-$0.16
-
Expected
-$0.21
-$0.32
-$0.12
-$0.18
-$0.26
Surprise
-20.47%
54.18%
-19.54%
-11.11%
-
Codexis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Codexis stock?
Codexis (CDXS) has a market cap of $203M as of July 06, 2024.
What is the P/E ratio for Codexis stock?
The price to earnings (P/E) ratio for Codexis (CDXS) stock is 0 as of July 06, 2024.
Does Codexis stock pay dividends?
No, Codexis (CDXS) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Codexis dividend payment date?
Codexis (CDXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Codexis?
Codexis (CDXS) has a beta rating of 2.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Codexis stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.